Who
Michael Stewart Lee
Director
Company insider
Files Form 4 as: Director, Fate Therapeutics; Director, IGM Biosciences; Director, Shattuck Labs.
In numbers
- Trades disclosed
- 47
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 31 Jul 2018
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | FATE Fate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —87,900 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | FATE Fate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —87,900 at $0.00 | filing |
| 14 Aug 2025filed 14 Aug 2025 | IGM Biosciences | SEC FORM 4 Code D | —12,712 | filing |
| 14 Jul 2025filed 16 Jul 2025 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,150 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | IGM Biosciences | SEC FORM 4 Code A | —828 at $0.00 | filing |
| 29 May 2025filed 30 May 2025 | FATE Fate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | IGM Biosciences | SEC FORM 4 Code A | —828 at $0.00 | filing |
| 31 Dec 2024filed 2 Jan 2025 | IGM Biosciences | SEC FORM 4 Code A | —1,734 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | IGM Biosciences | SEC FORM 4 Code A | —1,734 at $0.00 | filing |
| 28 Jun 2024filed 2 Jul 2024 | IGM Biosciences | SEC FORM 4 Code A | —1,734 at $0.00 | filing |
| 21 Jun 2024filed 21 Jun 2024 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,700 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | FATE Fate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 29 Mar 2024filed 2 Apr 2024 | IGM Biosciences | SEC FORM 4 Code A | —1,734 at $0.00 | filing |
| 12 Mar 2024filed 14 Mar 2024 | IGM Biosciencesoption or derivative | SEC FORM 4 Code A | —29,400 at $0.00 | filing |
| 29 Dec 2023filed 3 Jan 2024 | IGM Biosciences | SEC FORM 4 Code A | —492 at $0.00 | filing |
| 29 Sep 2023filed 3 Oct 2023 | IGM Biosciences | SEC FORM 4 Code A | —492 at $0.00 | filing |
| 30 Jun 2023filed 3 Jul 2023 | IGM Biosciences | SEC FORM 4 Code A | —492 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | FATE Fate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 26 May 2023filed 31 May 2023 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,258 at $0.00 | filing |
| 4 Apr 2023filed 6 Apr 2023 | IGM Biosciencesoption or derivative | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.